Seattle Children’s shared a post on LinkedIn:
“Congratulations to Seattle Children’s Rebecca Ronsley, MD, FRCPC, on receiving a $330k Scholar Grant from the St. Baldrick’s Foundation’s to support her team’s work evaluating a potential therapy for medulloblastoma, the most common malignant brain tumor in children.
This grant will support the first-ever hormonal therapy trial for pediatric brain tumors, offering new hope for families and marking a significant step toward changing the standard of care for one of the most devastating childhood cancers.”
More Posts Featuring Seattle Children’s.